BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $1.28B (100.0% shares, 0.0% debt)

Holdings (7)

MNST MONSTER BEVERAGE CORP NEW 34.1%

Value $436M Shares 8,295,690 Est. Cost $36.99 Unrealized +43.3%

AXON AXON ENTERPRISE INC 33.5%

Value $429M Shares 722,421 Est. Cost $27.50 Unrealized +1878.3%

STAA STAAR SURGICAL CO 20.6%

Value $264M Shares 10,848,631 Est. Cost $14.70 Unrealized +94.2%

IWM ISHARES TR 9.0%

Value $115M Shares 519,920 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 1.6%

Value $20.94M Shares 41,666,255 Est. Cost $1.06 Unrealized -30.6%

IMDX ONCOCYTE CORP 1.2%

Value $14.86M Shares 6,244,405 Est. Cost $3.13 Unrealized -13.2%

SER SERINA THERAPEUTICS INC 0.0%

Value $427K Shares 85,219 Est. Cost $14.17 Unrealized -58.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	8,295,690	$436M	34.1%	$36.99	+43.3%	COM	61174X109
AXON	AXON ENTERPRISE INC	722,421	$429M	33.5%	$27.50	+1878.3%	COM	05464C101
STAA	STAAR SURGICAL CO	10,848,631	$264M	20.6%	$14.70	+94.2%	COM PAR $0.01	852312305
IWM	ISHARES TR	519,920	$115M	9.0%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS IN	41,666,255	$20.94M	1.6%	$1.06	-30.6%	COM	53566P109
IMDX	ONCOCYTE CORP	6,244,405	$14.86M	1.2%	$3.13	-13.2%	COM NEW	68235C206
SER	SERINA THERAPEUTICS INC	85,219	$427K	0.0%	$14.17	-58.5%	COM SHS	81751A108